HCM - ハチソン・チャイナ・メディテック (Hutchison China MediTech Limited)

HCMのニュース

   Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London  2020/10/01 10:30:08 South China Morning Post
Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to receive approvals to sell its endocrine and lung cancer drugs in China by June next year, chief executive officer Christian Hogg said.The cancer drugs manufacturing and innovation unit of billionaire Li Ka-shing‘s conglomerate CK Hutchison, plans to triple the size of its marketing team over the next three years in anticipation of the green light, he added. That will take the…
   Hill Country Memorial Hospital Enhances Patient Safety with Addition of RLDatix's Surveillance Solution  2020/09/09 11:55:00 PR Newswire
CHICAGO, Sept. 9, 2020 /PRNewswire/ -- RLDatix, the leading global provider of intelligent patient safety solutions, today announced that Hill Country Memorial (HCM), a non-profit, acute care community hospital with beds in Fredericksburg, Texas, has signed an agreement to implement…
   Hutchison China MediTech : 2020 INterim Report | MarketScreener  2020/08/14 08:33:09 MarketScreener
Potential registration study start - in indolent NHL in China; … | August 14, 2020
   Chi-Med teams up with Lilly to commercialize Elunate in China (NASDAQ:HCM)  2020/07/28 07:49:07 Seeking Alpha
Hutchison China MediTech (NASDAQ:HCM) and Eli Lilly (NYSE:LLY) amend their 2013 License and Collaboration Agreement for Fruquintinib. Under the terms of th
   Chi-Med on go with study of HMPL-306 in blood cancer in China (NASDAQ:HCM)  2020/07/24 07:20:36 Seeking Alpha
Hutchison China MediTech (NASDAQ:HCM) has initiated a Phase I study of HMPL-306, its novel selective small molecule dual inhibitor of isocitrate dehydrogen
   Howard Capital Management Announces Retirement of Longtime President Bill Martin  2020/03/27 13:59:00 Benzinga Feeds
ATLANTA , March 27, 2020 /PRNewswire/ -- Howard Capital Management, Inc. (HCM), an SEC-registered investment advisory firm, announced today that president Bill Martin will retire after five years of leading the company. HCM's controller, Chris Ferguson , has been appointed his successor. "Through his leadership, Bill has taken this firm to new heights, and he will be missed dearly by all of us," said Vance Howard , CEO of HCM. "We're thrilled for Bill as he enters the next chapter of … Full story available on Benzinga.com
   Hutchison China MediTech : Phase II Savolitinib / Imfinzi® Combination Data | MarketScreener  2020/02/10 07:08:46 MarketScreener
RNS Reach Story Go to market news section … | February 10, 2020
   Hutchison China MediTech : Chi-Med to Present at JP Morgan Conference | MarketScreener  2020/01/06 07:08:15 MarketScreener
RNS Reach Story Go to market news section … | January 6, 2020
   Workday talks machine learning and the future of human capital management | ZDNet  2019/11/25 22:25:39 ZDNet
The head of HCM (human capital management) at Workday explains how machine learning and data are shaping how large organizations manage talent, retain employees, and execute quickly.
   Hutchison China MediTech : Chi-Med Highlights Presentations at 2019 ESMO Asia | MarketScreener  2019/11/25 07:53:22 MarketScreener
RNS Reach Story Go to market news section … | November 25, 2019
   Howard Capital Management Announces Retirement of Longtime President Bill Martin  2020/03/27 13:59:00 Benzinga Feeds
ATLANTA , March 27, 2020 /PRNewswire/ -- Howard Capital Management, Inc. (HCM), an SEC-registered investment advisory firm, announced today that president Bill Martin will retire after five years of leading the company. HCM's controller, Chris Ferguson , has been appointed his successor. "Through his leadership, Bill has taken this firm to new heights, and he will be missed dearly by all of us," said Vance Howard , CEO of HCM. "We're thrilled for Bill as he enters the next chapter of … Full story available on Benzinga.com
   Hutchison China MediTech : Phase II Savolitinib / Imfinzi® Combination Data | MarketScreener  2020/02/10 07:08:46 MarketScreener
RNS Reach Story Go to market news section … | February 10, 2020
   Hutchison China MediTech : Chi-Med to Present at JP Morgan Conference | MarketScreener  2020/01/06 07:08:15 MarketScreener
RNS Reach Story Go to market news section … | January 6, 2020
   Workday talks machine learning and the future of human capital management | ZDNet  2019/11/25 22:25:39 ZDNet
The head of HCM (human capital management) at Workday explains how machine learning and data are shaping how large organizations manage talent, retain employees, and execute quickly.
   Hutchison China MediTech : Chi-Med Highlights Presentations at 2019 ESMO Asia | MarketScreener  2019/11/25 07:53:22 MarketScreener
RNS Reach Story Go to market news section … | November 25, 2019

calendar